Results 231 to 240 of about 95,287 (303)
Risk of Type II Diabetes Mellitus Among B‐Cell Non‐Hodgkin's Lymphoma Survivors
ABSTRACT Purpose Advancing therapies have increased B‐cell Non‐Hodgkin's Lymphoma (B‐NHL) patient survival. However, data are limited on the risk of type II diabetes mellitus (type II DM) in adult survivors following treatment. This study examines the risk of type II DM among a Utah population of B‐NHL survivors, compared to the general population ...
Ellenor Chi +9 more
wiley +1 more source
Out-of-Office Blood Pressure Measurements in Patients with Heart Failure Registry Study (OOBPM-HF study) in China: study protocol, rationale and design. [PDF]
Miao H +5 more
europepmc +1 more source
Exploring Stakeholder Perceptions and Experience of Biosimilar Insulin Switching: A Scoping Review
This scoping review has systematically mapped the existing literature on stakeholder perceptions and experience of biosimilar insulin switches. It shows that there is a lack of high‐quality context‐specific research in this area, and more needs to be done to understand this topic. ABSTRACT Background The option to switch patients to more cost‐effective
Ben Hindley +4 more
wiley +1 more source
Blocked Atrial Bigeminy as an Unusual Cause of Bradycardia: A Case Report. [PDF]
Skakun O +4 more
europepmc +1 more source
ABSTRACT Background and Aims This systematic review and meta‐analysis aimed to compare the clinical outcomes of antihypertensive medication administration at bedtime versus morning, focusing on major adverse cardiovascular events (MACE), mortality, and secondary cardiovascular outcomes in hypertensive patients.
Pouria Azami +6 more
wiley +1 more source
Cardiovascular Assessments in Children and Adolescents With Hypertension. [PDF]
Sathik N +5 more
europepmc +1 more source
From Molecule to Meaning: Neuronopathic Biomarkers and Clinical Relevance in GM1
ABSTRACT GM1 gangliosidosis is a rare, progressively neurodegenerative lysosomal storage disorder characterized by profound central nervous system involvement and substantial clinical heterogeneity. The development of reliable biomarkers is essential for tracking disease progression, stratifying patients, and advancing clinical trial readiness. Primary
Krista Casazza +3 more
wiley +1 more source
Ambulatory blood pressure monitoring
openaire +3 more sources

